CompletedPhase 1NCT05559983
Dose Escalation Study to Evaluate the Safety and Immunogenicity of the Cholera Conjugate Vaccine in Healthy Adults
Studying Cholera
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- International Vaccine Institute
- Principal Investigator
- Anh Wartel, MD+82 2 8811 274
- Intervention
- OSP:rTTHc Cholera Conjugate Vaccine Cohort A(biological)
- Enrollment
- 150 enrolled
- Eligibility
- 19-45 years · All sexes
- Timeline
- 2022 – 2024
Study locations (3)
- The Catholic University of Korea Seoul St. Mary's Hospital, Seoul, South Korea
- CHA Bundang Medical Center (CBMC) of CHA University, Seoul, South Korea
- Soon Chun Hyang University Hospital, Seoul, South Korea
Collaborators
EuBiologics Co.,Ltd · Massachusetts General Hospital
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05559983 on ClinicalTrials.govOther trials for Cholera
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07509047Age-descending Study to Evaluate the Safety and Immunogenicity of the Cholera Conjugate Vaccine in Adults and ChildrenInternational Vaccine Institute
- RECRUITINGPHASE4NCT07487077Extended Dosing Intervals Trial for Oral Cholera Vaccine, KenyaAlbert B. Sabin Vaccine Institute
- RECRUITINGPHASE3NCT07304284Trial to Evaluate Immunogenicity Non-Inferiority, Safety and Lot-to-Lot Consistency of Biovac OCV-S to Euvichol®-PlusInternational Vaccine Institute
- RECRUITINGNANCT06455852Vaccine- and Infection-derived Correlates of Protection for Cholera.Massachusetts General Hospital
- RECRUITINGNANCT06498817Testing a Scalable Model of the Cholera Hospital-Based Intervention for 7 Days (CHoBI7)Johns Hopkins Bloomberg School of Public Health
- RECRUITINGNANCT06003816Cholera-Hospital-Based-Intervention-for-7-Days (CHoBI7) Water, Sanitation, and Hygiene (WASH) Case Area Targeted Intervention (CATI)Johns Hopkins Bloomberg School of Public Health
- RECRUITINGNANCT05166850Preventative Intervention for Cholera for 7 DaysJohns Hopkins Bloomberg School of Public Health
- ACTIVE NOT RECRUITINGPHASE2NCT04326478Single Dose Azithromycin to Prevent Cholera in ChildrenMassachusetts General Hospital